Nelarabine
Summary of product characteristics
Effective Time
20221105
Version
2
Spl Product Data Elements
Nelarabine Nelarabine NELARABINE NELARABINE HYDROCHLORIC ACID SODIUM CHLORIDE SODIUM HYDROXIDE WATER
Application Number
ANDA215037
Brand Name
Nelarabine
Generic Name
Nelarabine
Product Ndc
70771-1685
Product Type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1685-1 Nelarabine Injection 250 mg/5 mL (5 mg/mL) 50 mL Single-Dose Vial For Intravenous Infusion Only Rx Only NDC 70771-1685-1 Nelarabine Injection 250 mg/5 mL (5 mg/mL) 50 mL Single-Dose Vial Carton For Intravenous Infusion Only Rx Only vial label
Spl Unclassified Section
.
1 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.